Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Serotonin receptors in depression and anxiety: Insights from animal studies
Elżbieta Żmudzka, Kinga Sałaciak, Jacek Sapa, et al.
Life Sciences (2018) Vol. 210, pp. 106-124
Closed Access | Times Cited: 154
Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review
Karanvir Singh, Rohit Pal, Shah Alam Khan, et al.
Journal of Molecular Structure (2021) Vol. 1237, pp. 130369-130369
Closed Access | Times Cited: 82
Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review
Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 7, pp. 983-1016
Closed Access | Times Cited: 9
Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination
Lhotse Hei Lui Ng, Yuhua Huang, Lei Han, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
Kinga Sałaciak, Karolina Pytka
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1114-1136
Open Access | Times Cited: 47
Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases
Alejandro Quintero-Villegas, Sergio Iván Valdés‐Ferrer
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 27
Neuroprotective efficacy of different levels of high-frequency repetitive transcranial magnetic stimulation in mice with CUMS-induced depression: Involvement of the p11/BDNF/Homer1a signaling pathway
Chengchao Zuo, Huấn Cao, Fengfei Ding, et al.
Journal of Psychiatric Research (2020) Vol. 125, pp. 152-163
Open Access | Times Cited: 38
Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
Gustavo Roberto Villas Boas, Stefânia Neiva Lavorato, Marina Meirelles Paes, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 148-148
Open Access | Times Cited: 27
Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties
Tomasz Wichur, Justyna Godyń, Izabella Góral, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113792-113792
Open Access | Times Cited: 24
Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine
Vivian B. Neis, Luis E.B. Bettio, Morgana Moretti, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 173, pp. 44-50
Closed Access | Times Cited: 30
The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies
Zuleide Maria Ignácio, A.V. Calixto, Ritele Hernandez da Silva, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 86, pp. 36-50
Closed Access | Times Cited: 29
The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: A systematic review
Natalie Gottlieb, Tse-Yi Li, Allan H. Young, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 12, pp. 1167-1181
Open Access | Times Cited: 9
Hippocampal astrocyte atrophy in a mouse depression model induced by corticosterone is reversed by fluoxetine instead of benzodiazepine diazepam
Yunan Zhao, Zixuan Lin, Lin Chen, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 83, pp. 99-109
Closed Access | Times Cited: 26
Inhibition of Rho kinase by GSK 269962 reverses both corticosterone-induced detrusor overactivity and depression-like behaviour in rats
Andrzej Wróbel, Anna Serefko, Ewa Rechberger, et al.
European Journal of Pharmacology (2018) Vol. 837, pp. 127-136
Closed Access | Times Cited: 23
The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress
Monika Głuch‐Lutwin, Kinga Sałaciak, Alicja Gawalska, et al.
Psychopharmacology (2021) Vol. 238, Iss. 8, pp. 2249-2260
Open Access | Times Cited: 17
Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
Wei Zheng, Yanling Zhou, Chengyu Wang, et al.
PeerJ (2021) Vol. 9, pp. e10989-e10989
Open Access | Times Cited: 14
Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT3) receptors in Metazoa
Santosh T. R. B. Rao, Ilona Turek, Helen Irving
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281507-e0281507
Open Access | Times Cited: 5
HBK-14 and HBK-15, triple 5-HT 1A , 5-HT 7 and 5-HT 3 antagonists with potent antidepressant- and anxiolytic-like properties, increase seizure threshold in various seizure tests in mice
Karolina Pytka, Katarzyna Socała, Anna Rapacz, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 79, pp. 378-385
Closed Access | Times Cited: 15
HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling
Karolina Pytka, Monika Głuch‐Lutwin, Elżbieta Żmudzka, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 15
Stereospecific Synthesis of Highly Substituted Piperazines via an One-Pot Three Component Ring-Opening Cyclization from N-Activated Aziridines, Anilines, and Propargyl Carbonates
Navya Chauhan, Sajan Pradhan, Manas K. Ghorai
The Journal of Organic Chemistry (2018) Vol. 84, Iss. 4, pp. 1757-1765
Closed Access | Times Cited: 14
Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model
Magdalena Kotańska, Kamil Mika, Kinga Sałaciak, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 196, pp. 172974-172974
Open Access | Times Cited: 7
Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice
Elżbieta Żmudzka, Klaudia Lustyk, Kinga Sałaciak, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 399-399
Open Access | Times Cited: 2
The 5-HT1A receptor biased agonist, NLX-204, shows rapid-acting antidepressant-like properties and neurochemical changes in two mouse models of depression
Monika Głuch‐Lutwin, Kinga Sałaciak, Karolina Pytka, et al.
Behavioural Brain Research (2022) Vol. 438, pp. 114207-114207
Closed Access | Times Cited: 4
Repetitive transcranial magnetic stimulation and fluoxetine attenuate astroglial activation and benefit behaviours in a chronic unpredictable mild stress mouse model of depression
Qianfa Yuan, Yuying Lei, Kai Yu, et al.
The World Journal of Biological Psychiatry (2023) Vol. 25, Iss. 2, pp. 82-94
Closed Access | Times Cited: 2
Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT1A and D2 Receptors
Kinga Sałaciak, Natalia Malikowska‐Racia, Klaudia Lustyk, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 744-744
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top